ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.5560-2A>C (rs1566521710)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Centre for Mendelian Genomics,University Medical Centre Ljubljana RCV000681617 SCV000807652 likely pathogenic Myopathy, distal, 1 2018-09-13 criteria provided, single submitter clinical testing The variant c.5560-2A>C (NM_000257.3) in gene MYH7 causes a change at the acceptor site of consensus splicing sequence required for proper exon splicing and is located 2 basepair(s) from the exon-intron junction. The variant is not recorded in the database of populational genetic variation - dbSNP v138 and was not present among 60 thousand control subjects of the ExAC project. The variant has not yet been reported in patients with similar clinical presentation. In accordance with ACMG/AMP standards and guidelines for interpretation of sequence variants (Roberts et al. 2015) this variant is classified as a likely pathogenic variant (evidence categories: PM2, PP1-M, PP3, PP4). The identified variant in the MYH7 gene (c.5560-2A>C) has not been previously described in patients with similar phenotype, so it is not possible to conclusively assert the pathogenicity of identified finding. The following lines of evidence support the variant's pathogenicity: (1) the location in an evolutionary highly conserved gene region, (2) anticipated affect on splicing by modification of consensus splice site and the prediction of a likely effect on splicing using Human Splice Finder 3.0 tool, (3) the absence of variant from all control populations and (4) compatibility with the referred clinical presentation and autosomal dominant pattern of inheritance in the family. The identified variant in the MYH7 gene is predicted to result in in-frame deletion of exon 38 from MYH7 transcript. Variant with similar effect (skipping of exon 38) has previously been identified in patients with MYH7-related myopathies (Pajusalu et al., 2016; Fiorillo et al., 2016). Furtheremore, the segregation analysis has shown the same heterozygous variant in the MYH7 gene in the patient's affected relatives.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.